Ayala Pharmaceuticals (AL102 and AL101 in Wilmington, Delaware) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Ayala Pharmaceuticals (AL102 and AL101 in Wilmington, Delaware) General Information

Description

Portfolio of AL102 and related drug candidate AL101 assets based in Wilmington, Delaware. The asset portfolio consists of an investigational small molecule gamma-secretase inhibitor currently being evaluated in the randomized Phase 3 RINGSIDE international trial for the treatment of desmoid tumors.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Wilmington, DE
  • United States
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Acquirer
Immunome
Corporate Office
  • Wilmington, DE
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ayala Pharmaceuticals (AL102 and AL101 in Wilmington, Delaware) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ayala Pharmaceuticals (AL102 and AL101 in Wilmington, Delaware)‘s full profile, request access.

Request a free trial

Ayala Pharmaceuticals (AL102 and AL101 in Wilmington, Delaware) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Ayala Pharmaceuticals (AL102 and AL101 in Wilmington, Delaware)‘s full profile, request access.

Request a free trial

Ayala Pharmaceuticals (AL102 and AL101 in Wilmington, Delaware) FAQs

  • Where is Ayala Pharmaceuticals (AL102 and AL101 in Wilmington, Delaware) headquartered?

    Ayala Pharmaceuticals (AL102 and AL101 in Wilmington, Delaware) is headquartered in Wilmington, DE.

  • What industry is Ayala Pharmaceuticals (AL102 and AL101 in Wilmington, Delaware) in?

    Ayala Pharmaceuticals (AL102 and AL101 in Wilmington, Delaware)’s primary industry is Buildings and Property.

  • Is Ayala Pharmaceuticals (AL102 and AL101 in Wilmington, Delaware) a private or public company?

    Ayala Pharmaceuticals (AL102 and AL101 in Wilmington, Delaware) is a Private company.

  • What is the current valuation of Ayala Pharmaceuticals (AL102 and AL101 in Wilmington, Delaware)?

    The current valuation of Ayala Pharmaceuticals (AL102 and AL101 in Wilmington, Delaware) is .

  • What is Ayala Pharmaceuticals (AL102 and AL101 in Wilmington, Delaware)’s current revenue?

    The current revenue for Ayala Pharmaceuticals (AL102 and AL101 in Wilmington, Delaware) is .

  • Who are Ayala Pharmaceuticals (AL102 and AL101 in Wilmington, Delaware)’s investors?

    Ayala Pharmaceuticals has invested in Ayala Pharmaceuticals (AL102 and AL101 in Wilmington, Delaware).

  • When was Ayala Pharmaceuticals (AL102 and AL101 in Wilmington, Delaware) acquired?

    Ayala Pharmaceuticals (AL102 and AL101 in Wilmington, Delaware) was acquired on 25-Mar-2024.

  • Who acquired Ayala Pharmaceuticals (AL102 and AL101 in Wilmington, Delaware)?

    Ayala Pharmaceuticals (AL102 and AL101 in Wilmington, Delaware) was acquired by Immunome.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process